Evidence map›Paper›PMID 40569958›Full record

ArticlePloS one2025

Individualized diagnosis of rheumatoid arthritis: A rank-based qualitative T cell-related signature.

Hang Su, Xingyi Li, Yawei Li

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hang SuSchool of clinical medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Xingyi LiSchool of clinical medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Yawei LiSchool of Biology and Engineering, Guizhou Medical University, Guiyang, Guizhou, China.ORCID 0000-0002-2604-5253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease with persistent synovitis and joint destruction, leading to a huge economic and physical burden on patients. The detection of RA is important for the individual's guiding therapeutic. However, current signatures lacked enough effects for the diagnosis of RA. Here, a pariwise signature, including genes ICAM2 and OSTF1, was derived based on a rank-based method, which was called ICAM2-OSTF1 signature (IOS). The sensitivity and specificity of IOS in the training dataset were 87.39% and 86.79%, respectively. The accuracy of IOS was 91.07% in the validation dataset that contained a total of 280 samples from two independent datasets. Besides, when using eight methods, such as ssGSEA, xCell and TIMER, to quantitate the immune infiltration characteristics in RA. We found that RA presented elevated pro-inflammation immune infiltration and immune score. In addition, transcriptome analysis demonstrated that the consistent transcriptional differences between RA and healthy control were significantly enriched in some pathways typically related to the immune microenvironments, such as T cell activation. Finally, network analysis demonstrated that ICAM2, CXCL16, CKLF and SLPI may be related to the occurrence of RA. In brief, IOS can individually distinguish RA from healthy controls measured by different laboratories, and be an auxiliary test for diagnosing RA.

Indexed as

Arthritis, RheumatoidT-LymphocytesAdultFemaleGene Expression ProfilingHumansMaleMembrane ProteinsMiddle AgedPrecision MedicineTranscriptomeMembrane Proteins

Identifiers

PMID40569958
PMCPMC12200850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.